313 related articles for article (PubMed ID: 29324970)
1. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board.
Somashekhar SP; Sepúlveda MJ; Puglielli S; Norden AD; Shortliffe EH; Rohit Kumar C; Rauthan A; Arun Kumar N; Patil P; Rhee K; Ramya Y
Ann Oncol; 2018 Feb; 29(2):418-423. PubMed ID: 29324970
[TBL] [Abstract][Full Text] [Related]
2. Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China.
Zhao X; Zhang Y; Ma X; Chen Y; Xi J; Yin X; Kang H; Guan H; Dai Z; Liu D; Zhao F; Sun C; Li Z; Zhang S
Jpn J Clin Oncol; 2020 Aug; 50(8):852-858. PubMed ID: 32419014
[TBL] [Abstract][Full Text] [Related]
3. Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.
Zhou N; Zhang CT; Lv HY; Hao CX; Li TJ; Zhu JJ; Zhu H; Jiang M; Liu KW; Hou HL; Liu D; Li AQ; Zhang GQ; Tian ZB; Zhang XC
Oncologist; 2019 Jun; 24(6):812-819. PubMed ID: 30181315
[TBL] [Abstract][Full Text] [Related]
4. Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study.
Tian Y; Liu X; Wang Z; Cao S; Liu Z; Ji Q; Li Z; Sun Y; Zhou X; Wang D; Zhou Y
J Med Internet Res; 2020 Feb; 22(2):e14122. PubMed ID: 32130123
[TBL] [Abstract][Full Text] [Related]
5. Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study.
Liu C; Liu X; Wu F; Xie M; Feng Y; Hu C
J Med Internet Res; 2018 Sep; 20(9):e11087. PubMed ID: 30257820
[TBL] [Abstract][Full Text] [Related]
6. Early experience with Watson for oncology in Korean patients with colorectal cancer.
Kim EJ; Woo HS; Cho JH; Sym SJ; Baek JH; Lee WS; Kwon KA; Kim KO; Chung JW; Park DK; Kim YJ
PLoS One; 2019; 14(3):e0213640. PubMed ID: 30908530
[TBL] [Abstract][Full Text] [Related]
7. Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations.
Yu SH; Kim MS; Chung HS; Hwang EC; Jung SI; Kang TW; Kwon D
World J Urol; 2021 Feb; 39(2):407-413. PubMed ID: 32335733
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board.
Kim MS; Park HY; Kho BG; Park CK; Oh IJ; Kim YC; Kim S; Yun JS; Song SY; Na KJ; Jeong JU; Yoon MS; Ahn SJ; Yoo SW; Kang SR; Kwon SY; Bom HS; Jang WY; Kim IY; Lee JE; Jeong WG; Kim YH; Lee T; Choi YD
Transl Lung Cancer Res; 2020 Jun; 9(3):507-514. PubMed ID: 32676314
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Decision-Making for Colorectal Cancer Treatment Strategy: An Observational Study of Implementing Watson for Oncology in a 250-Case Cohort.
Aikemu B; Xue P; Hong H; Jia H; Wang C; Li S; Huang L; Ding X; Zhang H; Cai G; Lu A; Xie L; Li H; Zheng M; Sun J
Front Oncol; 2020; 10():594182. PubMed ID: 33628729
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Watson for oncology and clinicians' treatment recommendations for patients with breast cancer in Korea: A single center experience.
Park H; Kim KE; Choi YJ; Kim H; Kim DH; Kim KY; Kim JY; Bae SH; Yoon JA; Kang T
Indian J Cancer; 2023; 60(2):211-216. PubMed ID: 37530243
[TBL] [Abstract][Full Text] [Related]
11. Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience.
Pan H; Tao J; Qian M; Zhou W; Qian Y; Xie H; Jing S; Xu T; Zhang X; Dai Z; You M; Liu Y; Liu X; Wang S
Transl Cancer Res; 2019 Apr; 8(2):389-401. PubMed ID: 35116771
[TBL] [Abstract][Full Text] [Related]
12. Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non-small cell lung cancer patients at a lung cancer center in China.
Yao S; Wang R; Qian K; Zhang Y
Thorac Cancer; 2020 May; 11(5):1265-1270. PubMed ID: 32191394
[TBL] [Abstract][Full Text] [Related]
13. Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in Korea.
Lee WS; Ahn SM; Chung JW; Kim KO; Kwon KA; Kim Y; Sym S; Shin D; Park I; Lee U; Baek JH
JCO Clin Cancer Inform; 2018 Dec; 2():1-8. PubMed ID: 30652564
[TBL] [Abstract][Full Text] [Related]
14. Comparison of an oncology clinical decision-support system's recommendations with actual treatment decisions.
Suwanvecho S; Suwanrusme H; Jirakulaporn T; Issarachai S; Taechakraichana N; Lungchukiet P; Decha W; Boonpakdee W; Thanakarn N; Wongrattananon P; Preininger AM; Solomon M; Wang S; Hekmat R; Dankwa-Mullan I; Shortliffe E; Patel VL; Arriaga Y; Jackson GP; Kiatikajornthada N
J Am Med Inform Assoc; 2021 Mar; 28(4):832-838. PubMed ID: 33517389
[TBL] [Abstract][Full Text] [Related]
15. Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis.
Zou FW; Tang YF; Liu CY; Ma JA; Hu CH
Front Genet; 2020; 11():200. PubMed ID: 32265980
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.
McNamara DM; Goldberg SL; Latts L; Atieh Graham DM; Waintraub SE; Norden AD; Landstrom C; Pecora AL; Hervey J; Schultz EV; Wang CK; Jungbluth N; Francis PM; Snowdon JL
Cancer Med; 2019 Nov; 8(15):6578-6584. PubMed ID: 31509353
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of Watson for Oncology in clinical application.
Jie Z; Zhiying Z; Li L
Sci Rep; 2021 Mar; 11(1):5792. PubMed ID: 33707577
[TBL] [Abstract][Full Text] [Related]
18. The Fidelity of Artificial Intelligence to Multidisciplinary Tumor Board Recommendations for Patients with Gastric Cancer: A Retrospective Study.
Park YE; Chae H
J Gastrointest Cancer; 2024 Mar; 55(1):365-372. PubMed ID: 37702851
[TBL] [Abstract][Full Text] [Related]
19. Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea.
Choi YI; Chung JW; Kim KO; Kwon KA; Kim YJ; Park DK; Ahn SM; Park SH; Sym SJ; Shin DB; Kim YS; Sung KH; Baek JH; Lee U
Can J Gastroenterol Hepatol; 2019; 2019():8072928. PubMed ID: 30854352
[TBL] [Abstract][Full Text] [Related]
20. Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma.
Yun HJ; Kim HJ; Kim SY; Lee YS; Lim CY; Chang HS; Park CS
Front Endocrinol (Lausanne); 2021; 12():585364. PubMed ID: 33746898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
